Leukemia Treatment Method and Composition
A method of inducing high anti-leukemia activity responsive to the combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia characterized as expressing phosphorylated (p)FLT3 kinase by a novel flow cytometry-based assay.
Attached files:Patents:US 20,100,227,849
Inventor(s):
BHALLA KAPIL N [US]
Type of Offer:
Licensing
« More Medical Patents